|
SPATA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.698860E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.115900E-02 |
| Normal-vs-Stage2 |
2.067200E-01 |
| Normal-vs-Stage3 |
2.426300E-02 |
| Normal-vs-Stage4 |
1.825770E-01 |
| Stage1-vs-Stage2 |
7.185000E-01 |
| Stage1-vs-Stage3 |
1.160180E-01 |
| Stage1-vs-Stage4 |
9.533600E-01 |
| Stage2-vs-Stage3 |
3.174600E-01 |
| Stage2-vs-Stage4 |
8.110000E-01 |
| Stage3-vs-Stage4 |
1.769970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.461100E-03 |
| Normal-vs-AfricanAmerican |
1.588590E-01 |
| Normal-vs-Asian |
8.026800E-01 |
| Caucasian-vs-AfricanAmerican |
2.481000E-01 |
| Caucasian-vs-Asian |
6.199400E-01 |
| AfricanAmerican-vs-Asian |
8.005800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.496900E-03 |
| Normal-vs-Female |
2.164200E-02 |
| Male-vs-Female |
8.596800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.866600E-01 |
| Normal-vs-Extreme_Weight |
2.465000E-01 |
| Normal-vs-Obese |
4.482800E-03 |
| Normal-vs-Extreme_Obese |
8.153400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.307400E-01 |
| Normal_Weight-vs-Obese |
1.705820E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.512400E-01 |
| Extreme_Weight-vs-Obese |
9.511500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.958800E-01 |
| Obese-vs-Extreme_Obese |
2.863000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.498000E-02 |
| Normal-vs-Age(41-60Yrs) |
8.10650000000468E-05 |
| Normal-vs-Age(61-80Yrs) |
2.036800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.078000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.402000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.520200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.952160E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.319400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.780180E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.551600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.63850000000676E-05 |
| Normal-VS-Type2 PRCC |
8.242000E-01 |
| Normal-VS-KIRP CIMP |
5.369600E-01 |
| Normal-VS-Unclassified PRCC |
1.021970E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.862910E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.103200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.541200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.892800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.155830E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.144200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.923800E-01 |
| Normal-vs-N1 |
1.843650E-02 |
| Normal-vs-N2 |
1.595550E-01 |
| N0-vs-N1 |
6.307500E-02 |
| N0-vs-N2 |
6.861800E-01 |
| N1-vs-N2 |
6.094600E-01 |
|
|
